Myriad Genetics, Inc.

NASDAQ: MYGN
Share price (5/31/24): $22.76
Market cap (5/31/24): $2.060 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

6 Myriad Genetics, Inc. Expert Interviews, now on BamSEC.

Powered by Tegus.

Financials Filter

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Automatic shelf registration

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Newcomer Lee Nisley

News Filter

Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA

•Full-Year Testing Volume Grew 35% Year-Over-Year, or 18% Ex-SneakPeek® Volume

Investor Presentation

Change in Directors, Officers or Compensation, Material Disclosure, Financial Statements or Exhibits

Material Definitive Agreement, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Confidential treatment order

Scanned paper annual report submission

Scanned paper annual report submission